ASCENDIS HEALTH LIMITED - Dealings in Securities by Directors

Dealings in Securities by Directors

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share Code: ASC
ISIN: ZAE000185005
('Ascendis' or 'the company')

Dealings in Securities by Directors

In terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements ("the Listings Requirements"),
the following information relating to dealings in securities by directors is disclosed:

 Directors:                             Gary Shayne and Crispian Dillon, non-executive directors
 Class of share:                        Ordinary shares
 Nature of transaction:                 Purchase on market
 Nature of interest:                    Indirect beneficial, Coast2Coast Capital (Pty) Ltd
 Date of transaction:                   29 November 2017
 Number of shares:                      110,000 shares
 Purchase price per share (low):        R15.39
 Purchase price per share (high):       R16.15
 Volume weighted average price:         R15.8784
 Total value of transaction:            R1,746,622.97

 Director:                              Dr Karsten Wellner, Chief Executive Officer
 Class of share:                        Ordinary shares
 Nature of transaction:                 Purchase on market
 Nature of interest:                    Direct beneficial
 Date of transaction:                   28 November 2017
 Number of shares:                      64,000 shares
 Purchase price per share (low):        R15.20
 Purchase price per share (high):       R15.50
 Volume weighted average price:         R15.4386
 Total value of transaction:            R988,071.09

 Director:                              Kieron Futter, Chief Financial Officer
 Class of share:                        Ordinary shares
 Nature of transaction:                 Purchase on market
 Nature of interest:                    Direct beneficial
 Date of transaction:                   28 November 2017
 Number of shares:                      26,000 shares
 Purchase price per share:              R14.90
 Total value of transaction:            R387,400.00

 Director:                              Dr Kinesh Pather, Independent non-executive director
 Class of share:                        Ordinary shares
 Nature of transaction:                 Purchase on market
 Nature of interest:                    Direct beneficial
 Date of transaction:                   28 November 2017
 Number of shares:                      13,000 shares
 Purchase price per share (low):        R14.99
 Purchase price per share (high):       R15.00
 Volume weighted average price:         R14.9989
 Total value of transaction:            R194,985.22

 Nature of interest:                    Indirect beneficial, Kinpat family trust
 Date of transaction:                   28 November 2017
 Number of shares:                      20,000 shares
 Purchase price per share (low):        R14.98
 Purchase price per share (high):       R15.00
 Volume weighted average price:         R14.9935
 Total value of transaction:            R299,869.02

Clearance in terms of paragraph 3.66 of the Listings Requirements has been obtained from the Chairman
of the Board.

30 November 2017

Johannesburg

Sponsor
Investec Bank Limited

Date: 30/11/2017 11:42:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.